218 related articles for article (PubMed ID: 34519868)
21. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.
Cormie P; Galvão DA; Spry N; Joseph D; Chee R; Taaffe DR; Chambers SK; Newton RU
BJU Int; 2015 Feb; 115(2):256-66. PubMed ID: 24467669
[TBL] [Abstract][Full Text] [Related]
22. Nutrition therapy with high intensity interval training to improve prostate cancer-related fatigue in men on androgen deprivation therapy: a study protocol.
Baguley BJ; Skinner TL; Leveritt MD; Wright OR
BMC Cancer; 2017 Jan; 17(1):1. PubMed ID: 28049525
[TBL] [Abstract][Full Text] [Related]
23. Experiences of Men With Prostate Cancer Participating in a Clinical Pathway With a Supervised Group-based Exercise Program to Combat Androgen Deprivation-Induced Side Effects: A Qualitative Focus Group Study.
Bultijnck R; Rammant E; Raes A; Vandecasteele N; Decaestecker K; Fonteyne V; Lumen N; Ost P; Deforche B
Semin Oncol Nurs; 2023 Jun; 39(3):151404. PubMed ID: 36925317
[TBL] [Abstract][Full Text] [Related]
24. Body image issues and attitudes towards exercise amongst men undergoing androgen deprivation therapy (ADT) following diagnosis of prostate cancer.
Gentili C; McClean S; Hackshaw-McGeagh L; Bahl A; Persad R; Harcourt D
Psychooncology; 2019 Aug; 28(8):1647-1653. PubMed ID: 31141623
[TBL] [Abstract][Full Text] [Related]
25. Sexual Motivators and Endorsement of Models Describing Sexual Response of Men Undergoing Androgen Deprivation Therapy for Advanced Prostate Cancer.
Fode M; Mosholt KS; Nielsen TK; Tolouee S; Giraldi A; Østergren PB; Azawi N
J Sex Med; 2020 Aug; 17(8):1538-1543. PubMed ID: 32448679
[TBL] [Abstract][Full Text] [Related]
26. Measuring testosterone and testosterone replacement therapy in men receiving androgen deprivation therapy for prostate cancer: A survey of UK uro-oncologists' opinions and practice.
Payne H; McMenemin R; Bahl A; Greene D; Staffurth J
Int J Clin Pract; 2019 Sep; 73(9):1-6. PubMed ID: 30414348
[TBL] [Abstract][Full Text] [Related]
27. Feasibility and safety of physical exercise in men with prostate cancer receiving androgen deprivation therapy and radiotherapy: a study protocol.
Bressi B; Iotti C; Cagliari M; Cavuto S; Fugazzaro S; Costi S
BMJ Open; 2022 Mar; 12(3):e048854. PubMed ID: 35292485
[TBL] [Abstract][Full Text] [Related]
28. A comparison of aerobic- and resistance-emphasised exercise on cardiometabolic health and quality of life in men receiving androgen deprivation therapy for prostate cancer: Protocol for a feasibility trial.
Murphy K; Kehoe B; Denieffe S; Hacking D; Fairman CM; Harrison M
Contemp Clin Trials; 2024 Jan; 136():107388. PubMed ID: 37972755
[TBL] [Abstract][Full Text] [Related]
29. Long-term effects of androgen deprivation therapy in prostate cancer patients.
Basaria S; Lieb J; Tang AM; DeWeese T; Carducci M; Eisenberger M; Dobs AS
Clin Endocrinol (Oxf); 2002 Jun; 56(6):779-86. PubMed ID: 12072048
[TBL] [Abstract][Full Text] [Related]
30. Exercise preferences among men with prostate cancer receiving androgen-deprivation therapy.
Harrington JM; Schwenke DC; Epstein DR
Oncol Nurs Forum; 2013 Sep; 40(5):E358-67. PubMed ID: 23989028
[TBL] [Abstract][Full Text] [Related]
31. Testosterone Recovery Profiles After Cessation of Androgen Deprivation Therapy for Prostate Cancer.
Nascimento B; Miranda EP; Jenkins LC; Benfante N; Schofield EA; Mulhall JP
J Sex Med; 2019 Jun; 16(6):872-879. PubMed ID: 31080102
[TBL] [Abstract][Full Text] [Related]
32. Exercise medicine for the management of androgen deprivation therapy-related side effects in prostate cancer.
Cormie P; Zopf EM
Urol Oncol; 2020 Feb; 38(2):62-70. PubMed ID: 30446448
[TBL] [Abstract][Full Text] [Related]
33. Quality of life in prostate cancer patients taking androgen deprivation therapy.
Dacal K; Sereika SM; Greenspan SL
J Am Geriatr Soc; 2006 Jan; 54(1):85-90. PubMed ID: 16420202
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial.
Owen PJ; Daly RM; Livingston PM; Mundell NL; Dalla Via J; Millar JL; Fraser SF
Trials; 2017 Oct; 18(1):451. PubMed ID: 28974267
[TBL] [Abstract][Full Text] [Related]
35. Androgen deprivation in veterans with prostate cancer: implications for skeletal health.
Wilcox A; Carnes ML; Moon TD; Tobias R; Baade H; Stamos E; Elliott ME
Ann Pharmacother; 2006 Dec; 40(12):2107-14. PubMed ID: 17132807
[TBL] [Abstract][Full Text] [Related]
36. Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy.
Storer TW; Miciek R; Travison TG
Asian J Androl; 2012 Mar; 14(2):204-21. PubMed ID: 22367184
[TBL] [Abstract][Full Text] [Related]
37. De-implementation of low value castration for men with prostate cancer: protocol for a theory-based, mixed methods approach to minimizing low value androgen deprivation therapy (DeADT).
Skolarus TA; Hawley ST; Wittmann DA; Forman J; Metreger T; Sparks JB; Zhu K; Caram MEV; Hollenbeck BK; Makarov DV; Leppert JT; Shelton JB; Shahinian V; Srinivasaraghavan S; Sales AE
Implement Sci; 2018 Nov; 13(1):144. PubMed ID: 30486836
[TBL] [Abstract][Full Text] [Related]
38. Body composition, fatigue and exercise in patients with prostate cancer undergoing androgen-deprivation therapy.
Newton RU; Jeffery E; Galvão DA; Peddle-McIntyre CJ; Spry N; Joseph D; Denham JW; Taaffe DR
BJU Int; 2018 Dec; 122(6):986-993. PubMed ID: 29750398
[TBL] [Abstract][Full Text] [Related]
39. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer.
Segal RJ; Reid RD; Courneya KS; Malone SC; Parliament MB; Scott CG; Venner PM; Quinney HA; Jones LW; D'Angelo ME; Wells GA
J Clin Oncol; 2003 May; 21(9):1653-9. PubMed ID: 12721238
[TBL] [Abstract][Full Text] [Related]
40. Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer.
Alberga AS; Segal RJ; Reid RD; Scott CG; Sigal RJ; Khandwala F; Jaffey J; Wells GA; Kenny GP
Support Care Cancer; 2012 May; 20(5):971-81. PubMed ID: 21538098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
